Gene · 8647
Papers3,310
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,310
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pharmacokinetics and Drug-Drug Interaction of Ocedurenone (KBP-5074) in vitro and in vivo. | Eur J Drug Metab Pharmacokinet | 2023 | 37357226 | PubTator, text mining | PubMed |
| Study of kaempferol in the treatment of COVID-19 combined with Chikungunya co-infection by network pharmacology and molecular docking technology. | Inform Med Unlocked | 2023 | 37346467 | PubTator, text mining | PubMed |
| Intrahepatic cholestasis of pregnancy after ovarian hyperstimulation syndrome with wild-type ABCB4 gene: a peculiar case and literature review. | BMC Womens Health | 2023 | 37330509 | PubTator, text mining | PubMed |
| Aagenaes syndrome/lymphedema cholestasis syndrome 1 is caused by a founder variant in the 5'-untranslated region of UNC45A. | J Hepatol | 2023 | 37328071 | PubTator, text mining | PubMed |
| Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis. | Front Pharmacol | 2023 | 37324459 | PubTator, text mining | PubMed |
| Heterogeneity in biomarkers, mitogenome and genetic disorders of the Arab population with special emphasis on large-scale whole-exome sequencing. | Arch Med Sci | 2023 | 37313193 | PubTator, text mining | PubMed |
| Macrophage inhibitory cytokine-1 aggravates diet-induced gallstone formation via increased ABCG5/ABCG8 expression. | PLoS One | 2023 | 37310967 | PubTator, text mining | PubMed |
| Genetic background and clinical characteristics of infantile hyperammonemia. | Transl Pediatr | 2023 | 37305718 | PubTator, text mining | PubMed |
| Network pharmacology-based research on the effect of angelicin on osteosarcoma and the underlying mechanism. | Aging (Albany NY) | 2023 | 37301545 | PubTator, text mining | PubMed |
The Combination of a Human Biomimetic Liver Microphysiology System with BIOLOGXsym, a Quantitative Systems Toxicology (QST) Modeling Platform for Macromolecules, Provides Mechanistic Understanding of Tocilizumab- and GGF2-Induced Liver Injury. | Int J Mol Sci | 2023 | 37298645 | PubTator, text mining | PubMed |
| Microphysiological Models for Mechanistic-Based Prediction of Idiosyncratic DILI. | Cells | 2023 | 37296597 | PubTator, text mining | PubMed |
| Dietary (poly)phenols mitigate inflammatory bowel disease: Therapeutic targets, mechanisms of action, and clinical observations. | Curr Res Food Sci | 2023 | 37266414 | PubTator, text mining | PubMed |
| Mechanistic investigation of liver injury induced by BMS-932481, an experimental ɣ-secretase modulator. | Toxicol Sci | 2023 | 37261863 | PubTator, text mining | PubMed |
| Systematic review: efficacy of therapies for cholestatic pruritus. | Ther Adv Gastroenterol | 2023 | 37255856 | PubTator, text mining | PubMed |
| Differential Expression of ABC Transporter Genes in Brain Vessels vs. Peripheral Tissues and Vessels from Human, Mouse and Rat. | Pharmaceutics | 2023 | 37242805 | PubTator, text mining | PubMed |
| Challenges in the Development and Application of Organ-on-Chips for Intranasal Drug Delivery Studies. | Pharmaceutics | 2023 | 37242799 | PubTator, text mining | PubMed |
| Structure Optimization of 12β-O-γ-Glutamyl Oleanolic Acid Derivatives Resulting in Potent FXR Antagonist/Modulator for NASH Therapy. | Pharmaceuticals (Basel) | 2023 | 37242541 | PubTator, text mining | PubMed |
| Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease. | Nutrients | 2023 | 37242293 | PubTator, text mining | PubMed |
| Comparative Transcriptomic Analysis of Three Common Liver Cell Lines. | Int J Mol Sci | 2023 | 37240140 | PubTator, text mining | PubMed |
| Establishment and Validation of a Novel Risk Score for Hepatocellular Carcinoma Based on Bile Acid and Bile Salt Metabolism-Related Genes. | Int J Mol Sci | 2023 | 37239939 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8647/papers?page=18